DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock
61 EUR
-0.4 (-0.65%)
DRW8 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of DRW8 get a neutral evaluation. Nothing too spectacular is happening here. DRW8 is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year DRW8 was profitable.
In the past year DRW8 had a positive cash flow from operations.
Of the past 5 years DRW8 4 years were profitable.
DRW8 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of DRW8 (3.99%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 8.02%, DRW8 is in line with its industry, outperforming 53.85% of the companies in the same industry.
DRW8 has a better Return On Invested Capital (7.67%) than 63.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROIC | 7.67% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 3.54%, DRW8 is in line with its industry, outperforming 43.08% of the companies in the same industry.
DRW8's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 6.02%, DRW8 is doing worse than 63.08% of the companies in the same industry.
DRW8's Operating Margin has improved in the last couple of years.
The Gross Margin of DRW8 (45.35%) is worse than 67.69% of its industry peers.
In the last couple of years the Gross Margin of DRW8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
DRW8 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DRW8 has less shares outstanding
The number of shares outstanding for DRW8 has been increased compared to 5 years ago.
The debt/assets ratio for DRW8 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.67 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.67, DRW8 is in line with its industry, outperforming 50.77% of the companies in the same industry.
The Debt to FCF ratio of DRW8 is 2.16, which is a good value as it means it would take DRW8, 2.16 years of fcf income to pay off all of its debts.
DRW8 has a better Debt to FCF ratio (2.16) than 81.54% of its industry peers.
DRW8 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DRW8 (0.10) is better than 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Altman-Z | 2.67 |
ROIC/WACC1.16
WACC6.63%
2.3 Liquidity
A Current Ratio of 1.76 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8's Current ratio of 1.76 is in line compared to the rest of the industry. DRW8 outperforms 53.85% of its industry peers.
A Quick Ratio of 1.03 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Quick ratio (1.03) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
DRW8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.68%.
The Earnings Per Share has been growing by 36.42% on average over the past years. This is a very strong growth
Looking at the last year, DRW8 shows a small growth in Revenue. The Revenue has grown by 2.14% in the last year.
Measured over the past years, DRW8 shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
3.2 Future
DRW8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.93% yearly.
DRW8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.15% yearly.
EPS Next Y5.11%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
EPS Next 5Y7.93%
Revenue Next Year2.9%
Revenue Next 2Y3.54%
Revenue Next 3Y3.68%
Revenue Next 5Y3.15%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.46, the valuation of DRW8 can be described as reasonable.
Based on the Price/Earnings ratio, DRW8 is valued cheaply inside the industry as 98.46% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.11. DRW8 is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 8.35 indicates a reasonable valuation of DRW8.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 93.85% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DRW8 to the average of the S&P500 Index (36.21), we can say DRW8 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.46 | ||
| Fwd PE | 8.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DRW8 is valued cheaper than 96.92% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.46% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.36 | ||
| EV/EBITDA | 3.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.85
PEG (5Y)0.26
EPS Next 2Y10.82%
EPS Next 3Y11.88%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.10%, DRW8 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.15, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 95.38% of the companies listed in the same industry.
DRW8's Dividend Yield is a higher than the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.1% |
5.2 History
The dividend of DRW8 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
DRW8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
FRA:DRW8 (12/2/2025, 11:36:01 AM)
61
-0.4 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.49%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.14B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts78.67
Price Target82.49 (35.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.1% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.47%
PT rev (3m)13.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.39%
EPS NY rev (3m)2.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.46 | ||
| Fwd PE | 8.35 | ||
| P/S | 0.33 | ||
| P/FCF | 8.36 | ||
| P/OCF | 5.64 | ||
| P/B | 0.76 | ||
| P/tB | 0.98 | ||
| EV/EBITDA | 3.36 |
EPS(TTM)6.45
EY10.57%
EPS(NY)7.3
Fwd EY11.97%
FCF(TTM)7.29
FCFY11.96%
OCF(TTM)10.82
OCFY17.74%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.85
PEG (5Y)0.26
Graham Number108
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROCE | 10.2% | ||
| ROIC | 7.67% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 10.67% | ||
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% | ||
| FCFM | 4% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 44.92% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 11.48 | ||
| Cash Conversion | 57.51% | ||
| Profit Quality | 113.22% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.67 |
F-Score7
WACC6.63%
ROIC/WACC1.16
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.11%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.9%
Revenue Next 2Y3.54%
Revenue Next 3Y3.68%
Revenue Next 5Y3.15%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.51%
EBIT Next 3Y29.6%
EBIT Next 5Y13.46%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%
DRAEGERWERK AG / DRW8.DE FAQ
Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?
ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.
What is the valuation status for DRW8 stock?
ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.
What is the profitability of DRW8 stock?
DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of DRAEGERWERK AG (DRW8.DE) stock?
The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 9.46 and the Price/Book (PB) ratio is 0.76.
Can you provide the expected EPS growth for DRW8 stock?
The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.11% in the next year.